A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer treatment without chemotherapy.
Resistance to therapy and tumor heterogeneity remain the fundamental drivers of treatment failure in oncology. While single-agent therapies have provided ...
Cancer therapy continues to evolve, with significant advances in precision techniques such as surgery, chemotherapy, immunotherapy, radiotherapy, and ...
HealthDay on MSN
Women more likely to survive cancer than men — at a cost
Key Takeaways Women are more likely to survive cancer than menHowever, they also are more likely to develop severe side ...
Every year, millions of people are diagnosed with cancer globally; however, current treatments are limited by disease complexity. A study published in the open-access journal in PLOS Biology by Tianyu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results